loading page

Non-invasive management of infants with SFTPC pathogenic variants
  • +2
  • Deborah R. Liptzin,
  • Matthew McGraw,
  • Timothy Stidham,
  • Jennifer Wambach (Guest Editor),
  • Robin Deterding
Deborah R. Liptzin
University of Colorado Anschutz Medical Campus Department of Pediatrics

Corresponding Author:[email protected]

Author Profile
Matthew McGraw
University of Rochester Medical Center
Author Profile
Timothy Stidham
Logan Health
Author Profile
Jennifer Wambach (Guest Editor)
Washington University in St Louis Department of Pediatrics
Author Profile
Robin Deterding
University of Colorado Anschutz Medical Campus Department of Pediatrics
Author Profile

Abstract

Pathogenic variants in the Surfactant Protein C gene ( SFTPC) result in fibrotic childhood interstitial lung disease (chILD). We previously reported three children with SFTPC pathogenic variants with respiratory failure who were supported by chronic invasive ventilation via tracheostomy as an alternative to lung transplantation or comfort care [(1)](#ref-0001). We present two children with SFTPC pathogenic variants treated with non-invasive ventilation (NIV) (Figure 1).
08 Aug 2023Submitted to Pediatric Pulmonology
08 Aug 2023Review(s) Completed, Editorial Evaluation Pending
08 Aug 2023Submission Checks Completed
08 Aug 2023Assigned to Editor
19 Aug 2023Editorial Decision: Revise Minor
19 Sep 20231st Revision Received
19 Sep 2023Submission Checks Completed
19 Sep 2023Assigned to Editor
19 Sep 2023Review(s) Completed, Editorial Evaluation Pending
26 Sep 2023Editorial Decision: Accept